Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing
Reexamination Certificate
2003-08-06
2009-02-03
Saucier, Sandra (Department: 1651)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
C424S094600, C424S093100, C435S183000, C435S195000, C435S197000
Reexamination Certificate
active
07485294
ABSTRACT:
Forms of colonic delivery suited to be used orally and designed for colonic delivery of active ingredients selected from the group comprising enzymes capable of inactivating macrolide antibiotics and related compounds, enzymes capable of inactivating quinolones, and β-lactamases.
REFERENCES:
patent: 3959457 (1976-05-01), Speaker et al.
patent: 5607671 (1997-03-01), Heino
patent: 6436461 (2002-08-01), Bouwmeesters et al.
patent: 6500423 (2002-12-01), Olshenitsky et al.
patent: 6531152 (2003-03-01), Lerner et al.
patent: 6632451 (2003-10-01), Penhasi et al.
patent: 7018629 (2006-03-01), Jacob et al.
patent: 2004/0067223 (2004-04-01), Jacob et al.
patent: 0 213 303 (1987-03-01), None
patent: 0 338 499 (1989-10-01), None
patent: 0 480 729 (1992-04-01), None
patent: 04-013724 (1992-01-01), None
patent: WO 8807865 (1988-10-01), None
patent: WO 92/00732 (1992-01-01), None
patent: WO 93/13757 (1993-01-01), None
patent: WO-95/05939 (1995-03-01), None
patent: WO-97/27843 (1997-08-01), None
patent: WO 98/15192 (1998-04-01), None
Munjeri, O., et al. Journal of Pharmaceutical Sciences. 1998, 87(8), 905-908.
Arthur, M. et al. “Heterogeneity of genes conferring high-level resistance to erythromycin by inactivation in enterobacteria” Annales de l'institut Pasteur, Microbiologie. 137(1.1) Jan./Feb. 1986, pp. 125-134. (Abstract Only).
Ounissi, H. and Courvalin, P. “Nucleotide sequence of the gene ereA encoding erythromycin esterase inE.coli”, Gene.1985, 35(3), pp. 271-278. (Abstract Only).
Noguchi, N., et al. “Regulation of Transcription of the mph(A) Gene for Macrolide 2′-Phosphotransferase I inEscherichia coli: Characterization of the Regulatory Gene mphR(A)” Journal of Bacteriology. 2000, 182(18), 5052-8.
Mathiowitz, E. “Oral Drug delivery, Small Intestine & Colon”, Encyclopedia of Controlled Drug Delivery, vols. 1-2. 1999, pp. 717-728.
Leonard F., et al., “Use of Beta-Lactamase-producing Anaerobes to prevent Ceftriaxone from Degrading Intestinal Resistance to Colonization” J. Infectious Disease. 1989, 160(2), 274-280 (Cas Abstract).
Aydin, Z. and Akbuga, J., “Preparation and evaluation of pectin beads”,Inter. J. Pharm., v. 137, p. 133-136, 1996.
Krishnaiah, Y.S.R., et al., “Evaluation of guar gum as compression coat for drug targeting to colon”,Inter. J. Pharm., v171, p. 137-146, 1998.
Milojevic, S., et al., “Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using 5-aminosalicylic acid pellets”,J. Cont. Release, v37, p. 75-84, 1996.
Munjeri, O., et al., “Hydrogel beads based on amidated pectins for colon-specific drug delivery: the role of chitosan in modifying drug release”,J. Cont. Release, v46, p. 273-278, 1997.
Rubinstein, A., et al., “In Vitro Evaluation of Calcium Pectinate: A Potential Colon-Specific Drug Delivery Carrier”,Pharm. Res., v.10:2, p. 258-263, 1993.
Rubinstein, A., et al., “Colonic Drug Delivery: Enhanced Release of Indomethacin from Cross-Linked Chondroitin matrix in Rat Cecal Content”,Pharm. Res., v9:2, p. 276-278, 1992.
Sriamornsak, P., “Investigation of pectin as a carrier for oral delivery of proteins using calcium nectinate gel beads”,Inter. J. Pharm., v169, p. 213-220, 1998.
Sriamornsak, P., “Effect of calcium concentration, hardening agent and drying condition on release characteristics of oral proteins from calcium pectinate gel beads”,Eur. J. Pharm. Sci., v8, p. 221-227, 1999.
Wakerly, Z., et al., “Pectin/Ethylcellulose Film Coating Formulations for colonic Drug Delivery”,Pharm. Res., v13:8, p. 1210-1212, 1996.
Andremont Antoine
Bourgeois Sandrine
Couvreur Patrick
Fattal Elias
Bradin David
Da Volterra
Intellectual Property / Technology Law
Kosar Aaron J
Saucier Sandra
LandOfFree
Galenic pectinate formulation for colon-targeted delivery of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Galenic pectinate formulation for colon-targeted delivery of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galenic pectinate formulation for colon-targeted delivery of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4067786